img

Global Swine Influenza Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Swine Influenza Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vaccines have been developed to protect against the virus that causes swine flu. There are two different brands of vaccine – Pandemrix and Celvapan.
Swine Influenza Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swine Influenza Vaccines market is projected to reach US$ 167.4 million in 2029, increasing from US$ 124 million in 2022, with the CAGR of 4.3% during the period of 2024 to 2029. Demand from Commodity Pig and Breeding Pig are the major drivers for the industry.
The swine influenza vaccines market is experiencing significant growth due to the increasing prevalence of swine influenza and the rising demand for efficient disease prevention in swine populations. Swine influenza vaccines play a vital role in controlling and preventing respiratory diseases in pigs. The market is driven by factors such as the growth of the swine industry, the need for improved animal health and welfare, and the implementation of strict biosecurity measures. Advancements in vaccine development, including the availability of more effective and targeted vaccines, are further contributing to market growth. However, challenges such as the emergence of new strains of swine influenza virus and the requirement for periodic vaccine updates may impact market expansion. With the continuous focus on swine health management, disease prevention, and sustainable swine production, the swine influenza vaccines market is expected to witness sustained growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Swine Influenza Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Chengdu TECBOND
Green Cross Veterinary
Hipra
MSD Animal Health (Merck)
Zoetis
CAHIC
Boehringer Ingelheim
Ceva
Ringpu Biology
DHN
Segment by Type
Live Vaccines
Killed Vaccines

Segment by Application


Commodity Pig
Breeding Pig

Segment by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Swine Influenza Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Swine Influenza Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Swine Influenza Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Swine Influenza Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Swine Influenza Vaccines introduction, etc. Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Swine Influenza Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Swine Influenza Vaccines Market Overview
1.1 Swine Influenza Vaccines Product Overview
1.2 Swine Influenza Vaccines Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Global Swine Influenza Vaccines Market Size by Type
1.3.1 Global Swine Influenza Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Swine Influenza Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Swine Influenza Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Swine Influenza Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Swine Influenza Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Swine Influenza Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Swine Influenza Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Swine Influenza Vaccines Sales Breakdown by Type (2018-2024)
2 Global Swine Influenza Vaccines Market Competition by Company
2.1 Global Top Players by Swine Influenza Vaccines Sales (2018-2024)
2.2 Global Top Players by Swine Influenza Vaccines Revenue (2018-2024)
2.3 Global Top Players by Swine Influenza Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Swine Influenza Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Swine Influenza Vaccines Market Competitive Situation and Trends
2.5.1 Swine Influenza Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Swine Influenza Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Influenza Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Swine Influenza Vaccines Market
2.8 Key Manufacturers Swine Influenza Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Swine Influenza Vaccines Status and Outlook by Region
3.1 Global Swine Influenza Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Swine Influenza Vaccines Historic Market Size by Region
3.2.1 Global Swine Influenza Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Swine Influenza Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Swine Influenza Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Swine Influenza Vaccines Forecasted Market Size by Region
3.3.1 Global Swine Influenza Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Swine Influenza Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Swine Influenza Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Swine Influenza Vaccines by Application
4.1 Swine Influenza Vaccines Market Segment by Application
4.1.1 Commodity Pig
4.1.2 Breeding Pig
4.2 Global Swine Influenza Vaccines Market Size by Application
4.2.1 Global Swine Influenza Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Swine Influenza Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Swine Influenza Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Swine Influenza Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Swine Influenza Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Swine Influenza Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Swine Influenza Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Swine Influenza Vaccines Sales Breakdown by Application (2018-2024)
5 North America Swine Influenza Vaccines by Country
5.1 North America Swine Influenza Vaccines Historic Market Size by Country
5.1.1 North America Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Swine Influenza Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Swine Influenza Vaccines Sales in Value by Country (2018-2024)
5.2 North America Swine Influenza Vaccines Forecasted Market Size by Country
5.2.1 North America Swine Influenza Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Swine Influenza Vaccines Sales in Value by Country (2024-2029)
6 Europe Swine Influenza Vaccines by Country
6.1 Europe Swine Influenza Vaccines Historic Market Size by Country
6.1.1 Europe Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Swine Influenza Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Swine Influenza Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Swine Influenza Vaccines Forecasted Market Size by Country
6.2.1 Europe Swine Influenza Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Swine Influenza Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Swine Influenza Vaccines by Region
7.1 Asia-Pacific Swine Influenza Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Swine Influenza Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Swine Influenza Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Swine Influenza Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Swine Influenza Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Swine Influenza Vaccines Sales in Value by Region (2024-2029)
8 Latin America Swine Influenza Vaccines by Country
8.1 Latin America Swine Influenza Vaccines Historic Market Size by Country
8.1.1 Latin America Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Swine Influenza Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Swine Influenza Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Swine Influenza Vaccines Forecasted Market Size by Country
8.2.1 Latin America Swine Influenza Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Swine Influenza Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Swine Influenza Vaccines by Country
9.1 Middle East and Africa Swine Influenza Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Swine Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Swine Influenza Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Swine Influenza Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Swine Influenza Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Swine Influenza Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Swine Influenza Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Chengdu TECBOND
10.1.1 Chengdu TECBOND Company Information
10.1.2 Chengdu TECBOND Introduction and Business Overview
10.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Chengdu TECBOND Swine Influenza Vaccines Products Offered
10.1.5 Chengdu TECBOND Recent Development
10.2 Green Cross Veterinary
10.2.1 Green Cross Veterinary Company Information
10.2.2 Green Cross Veterinary Introduction and Business Overview
10.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Green Cross Veterinary Swine Influenza Vaccines Products Offered
10.2.5 Green Cross Veterinary Recent Development
10.3 Hipra
10.3.1 Hipra Company Information
10.3.2 Hipra Introduction and Business Overview
10.3.3 Hipra Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Hipra Swine Influenza Vaccines Products Offered
10.3.5 Hipra Recent Development
10.4 MSD Animal Health (Merck)
10.4.1 MSD Animal Health (Merck) Company Information
10.4.2 MSD Animal Health (Merck) Introduction and Business Overview
10.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 MSD Animal Health (Merck) Swine Influenza Vaccines Products Offered
10.4.5 MSD Animal Health (Merck) Recent Development
10.5 Zoetis
10.5.1 Zoetis Company Information
10.5.2 Zoetis Introduction and Business Overview
10.5.3 Zoetis Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Zoetis Swine Influenza Vaccines Products Offered
10.5.5 Zoetis Recent Development
10.6 CAHIC
10.6.1 CAHIC Company Information
10.6.2 CAHIC Introduction and Business Overview
10.6.3 CAHIC Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 CAHIC Swine Influenza Vaccines Products Offered
10.6.5 CAHIC Recent Development
10.7 Boehringer Ingelheim
10.7.1 Boehringer Ingelheim Company Information
10.7.2 Boehringer Ingelheim Introduction and Business Overview
10.7.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Boehringer Ingelheim Swine Influenza Vaccines Products Offered
10.7.5 Boehringer Ingelheim Recent Development
10.8 Ceva
10.8.1 Ceva Company Information
10.8.2 Ceva Introduction and Business Overview
10.8.3 Ceva Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Ceva Swine Influenza Vaccines Products Offered
10.8.5 Ceva Recent Development
10.9 Ringpu Biology
10.9.1 Ringpu Biology Company Information
10.9.2 Ringpu Biology Introduction and Business Overview
10.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Ringpu Biology Swine Influenza Vaccines Products Offered
10.9.5 Ringpu Biology Recent Development
10.10 DHN
10.10.1 DHN Company Information
10.10.2 DHN Introduction and Business Overview
10.10.3 DHN Swine Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 DHN Swine Influenza Vaccines Products Offered
10.10.5 DHN Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Swine Influenza Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Swine Influenza Vaccines Industrial Chain Analysis
11.4 Swine Influenza Vaccines Market Dynamics
11.4.1 Swine Influenza Vaccines Industry Trends
11.4.2 Swine Influenza Vaccines Market Drivers
11.4.3 Swine Influenza Vaccines Market Challenges
11.4.4 Swine Influenza Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Swine Influenza Vaccines Distributors
12.3 Swine Influenza Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live Vaccines
Table 2. Major Company of Killed Vaccines
Table 3. Global Swine Influenza Vaccines Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Swine Influenza Vaccines Sales by Type (2018-2024) & (M Units)
Table 5. Global Swine Influenza Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Swine Influenza Vaccines Sales by Type (2018-2024) & (US& Million)
Table 7. Global Swine Influenza Vaccines Market Share in Value by Type (2018-2024)
Table 8. Global Swine Influenza Vaccines Price by Type (2018-2024) & (USD/K Unit)
Table 9. Global Swine Influenza Vaccines Sales by Type (2024-2029) & (M Units)
Table 10. Global Swine Influenza Vaccines Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Swine Influenza Vaccines Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Swine Influenza Vaccines Sales Market Share in Value by Type (2024-2029)
Table 13. Global Swine Influenza Vaccines Price by Type (2024-2029) & (USD/K Unit)
Table 14. North America Swine Influenza Vaccines Sales by Type (2018-2024) & (M Units)
Table 15. North America Swine Influenza Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Swine Influenza Vaccines Sales (M Units) by Type (2018-2024)
Table 17. Europe Swine Influenza Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Swine Influenza Vaccines Sales (M Units) by Type (2018-2024)
Table 19. Asia-Pacific Swine Influenza Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Swine Influenza Vaccines Sales (M Units) by Type (2018-2024)
Table 21. Latin America Swine Influenza Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Swine Influenza Vaccines Sales (M Units) by Type (2018-2024)
Table 23. Middle East and Africa Swine Influenza Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Swine Influenza Vaccines Sales by Company (2018-2024) & (M Units)
Table 25. Global Swine Influenza Vaccines Sales Share by Company (2018-2024)
Table 26. Global Swine Influenza Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Swine Influenza Vaccines Revenue Share by Company (2018-2024)
Table 28. Global Market Swine Influenza Vaccines Price by Company (2018-2024) & (USD/K Unit)
Table 29. Global Swine Influenza Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Swine Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Influenza Vaccines as of 2022)
Table 32. Date of Key Manufacturers Enter into Swine Influenza Vaccines Market
Table 33. Key Manufacturers Swine Influenza Vaccines Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Swine Influenza Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Swine Influenza Vaccines Sales by Region (2018-2024) & (M Units)
Table 37. Global Swine Influenza Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Swine Influenza Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Swine Influenza Vaccines Sales Market Share in Value by Region (2018-2024)
Table 40. Global Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 41. Global Swine Influenza Vaccines Sales by Region (2024-2029) & (M Units)
Table 42. Global Swine Influenza Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Swine Influenza Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Swine Influenza Vaccines Sales Market Share in Value by Region (2024-2029)
Table 45. Global Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2024-2029)
Table 46. Global Swine Influenza Vaccines Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Swine Influenza Vaccines Sales by Application (2018-2024) & (M Units)
Table 48. Global Swine Influenza Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Swine Influenza Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Swine Influenza Vaccines Sales Market Share in Value by Application (2018-2024)
Table 51. Global Swine Influenza Vaccines Price by Application (2018-2024) & (USD/K Unit)
Table 52. Global Swine Influenza Vaccines Sales by Application (2024-2029) & (M Units)
Table 53. Global Swine Influenza Vaccines Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Swine Influenza Vaccines Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Swine Influenza Vaccines Sales Market Share in Value by Application (2024-2029)
Table 56. Global Swine Influenza Vaccines Price by Application (2024-2029) & (USD/K Unit)
Table 57. North America Swine Influenza Vaccines Sales by Application (2018-2024) (M Units)
Table 58. North America Swine Influenza Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Swine Influenza Vaccines Sales by Application (2018-2024) (M Units)
Table 60. Europe Swine Influenza Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Swine Influenza Vaccines Sales by Application (2018-2024) (M Units)
Table 62. Asia-Pacific Swine Influenza Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Swine Influenza Vaccines Sales by Application (2018-2024) (M Units)
Table 64. Latin America Swine Influenza Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Swine Influenza Vaccines Sales by Application (2018-2024) (M Units)
Table 66. Middle East and Africa Swine Influenza Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Swine Influenza Vaccines Sales by Country (2018-2024) & (M Units)
Table 68. North America Swine Influenza Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Swine Influenza Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Swine Influenza Vaccines Sales Market Share in Value by Country (2018-2024)
Table 71. North America Swine Influenza Vaccines Sales by Country (2024-2029) & (M Units)
Table 72. North America Swine Influenza Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Swine Influenza Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Swine Influenza Vaccines Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Swine Influenza Vaccines Sales by Country (2018-2024) & (M Units)
Table 76. Europe Swine Influenza Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Swine Influenza Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Swine Influenza Vaccines Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Swine Influenza Vaccines Sales by Country (2024-2029) & (M Units)
Table 80. Europe Swine Influenza Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Swine Influenza Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Swine Influenza Vaccines Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Swine Influenza Vaccines Sales by Region (2018-2024) & (M Units)
Table 84. Asia-Pacific Swine Influenza Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Swine Influenza Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Swine Influenza Vaccines Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Swine Influenza Vaccines Sales by Region (2024-2029) & (M Units)
Table 88. Asia-Pacific Swine Influenza Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Swine Influenza Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Swine Influenza Vaccines Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Swine Influenza Vaccines Sales by Country (2018-2024) & (M Units)
Table 92. Latin America Swine Influenza Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Swine Influenza Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Swine Influenza Vaccines Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Swine Influenza Vaccines Sales by Country (2024-2029) & (M Units)
Table 96. Latin America Swine Influenza Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Swine Influenza Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Swine Influenza Vaccines Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Swine Influenza Vaccines Sales by Country (2018-2024) & (M Units)
Table 100. Middle East and Africa Swine Influenza Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Swine Influenza Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Swine Influenza Vaccines Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Swine Influenza Vaccines Sales by Country (2024-2029) & (M Units)
Table 104. Middle East and Africa Swine Influenza Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Swine Influenza Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Swine Influenza Vaccines Sales Market Share in Value by Country (2024-2029)
Table 107. Chengdu TECBOND Company Information
Table 108. Chengdu TECBOND Introduction and Business Overview
Table 109. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 110. Chengdu TECBOND Swine Influenza Vaccines Product
Table 111. Chengdu TECBOND Recent Development
Table 112. Green Cross Veterinary Company Information
Table 113. Green Cross Veterinary Introduction and Business Overview
Table 114. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 115. Green Cross Veterinary Swine Influenza Vaccines Product
Table 116. Green Cross Veterinary Recent Development
Table 117. Hipra Company Information
Table 118. Hipra Introduction and Business Overview
Table 119. Hipra Swine Influenza Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 120. Hipra Swine Influenza Vaccines Product
Table 121. Hipra Recent Development
Table 122. MSD Animal Health (Merck) Company Information
Table 123. MSD Animal Health (Merck) Introduction and Business Overview
Table 124. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 125. MSD Animal Health (Merck) Swine Influenza Vaccines Product
Table 126. MSD Animal Health (Merck) Recent Development
Table 127. Zoetis Company Information
Table 128. Zoetis Introduction and Business Overview
Table 129. Zoetis Swine Influenza Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 130. Zoetis Swine Influenza Vaccines Product
Table 131. Zoetis Recent Development
Table 132. CAHIC Company Information
Table 133. CAHIC Introduction and Business Overview
Table 134. CAHIC Swine Influenza Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 135. CAHIC Swine Influenza Vaccines Product
Table 136. CAHIC Recent Development
Table 137. Boehringer Ingelheim Company Information
Table 138. Boehringer Ingelheim Introduction and Business Overview
Table 139. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 140. Boehringer Ingelheim Swine Influenza Vaccines Product
Table 141. Boehringer Ingelheim Recent Development
Table 142. Ceva Company Information
Table 143. Ceva Introduction and Business Overview
Table 144. Ceva Swine Influenza Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 145. Ceva Swine Influenza Vaccines Product
Table 146. Ceva Recent Development
Table 147. Ringpu Biology Company Information
Table 148. Ringpu Biology Introduction and Business Overview
Table 149. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 150. Ringpu Biology Swine Influenza Vaccines Product
Table 151. Ringpu Biology Recent Development
Table 152. DHN Company Information
Table 153. DHN Introduction and Business Overview
Table 154. DHN Swine Influenza Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 155. DHN Swine Influenza Vaccines Product
Table 156. DHN Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Swine Influenza Vaccines Market Trends
Table 160. Swine Influenza Vaccines Market Drivers
Table 161. Swine Influenza Vaccines Market Challenges
Table 162. Swine Influenza Vaccines Market Restraints
Table 163. Swine Influenza Vaccines Distributors List
Table 164. Swine Influenza Vaccines Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Influenza Vaccines Product Picture
Figure 2. Global Swine Influenza Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Swine Influenza Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Swine Influenza Vaccines Sales Status and Outlook (2018-2029) & (M Units)
Figure 5. Product Picture of Live Vaccines
Figure 6. Global Live Vaccines Sales YoY Growth (2018-2029) & (M Units)
Figure 7. Product Picture of Killed Vaccines
Figure 8. Global Killed Vaccines Sales YoY Growth (2018-2029) & (M Units)
Figure 9. Global Swine Influenza Vaccines Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Swine Influenza Vaccines Sales Market Share by Type in 2022 & 2029
Figure 11. North America Swine Influenza Vaccines Sales Market Share in Volume by Type in 2022
Figure 12. North America Swine Influenza Vaccines Sales Market Share in Value by Type in 2022
Figure 13. Europe Swine Influenza Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. Europe Swine Influenza Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Swine Influenza Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Swine Influenza Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Latin America Swine Influenza Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Swine Influenza Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Swine Influenza Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Swine Influenza Vaccines Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Influenza Vaccines Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Influenza Vaccines Revenue in 2022
Figure 23. Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Commodity Pig
Figure 25. Global Commodity Pig Sales YoY Growth (2018-2029) & (M Units)
Figure 26. Product Picture of Breeding Pig
Figure 27. Global Breeding Pig Sales YoY Growth (2018-2029) & (M Units)
Figure 28. Global Swine Influenza Vaccines Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Swine Influenza Vaccines Sales Market Share by Application in 2022 & 2029
Figure 30. North America Swine Influenza Vaccines Sales Market Share in Volume by Application in 2022
Figure 31. North America Swine Influenza Vaccines Sales Market Share in Value by Application in 2022
Figure 32. Europe Swine Influenza Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. Europe Swine Influenza Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Swine Influenza Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Swine Influenza Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Latin America Swine Influenza Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Swine Influenza Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Swine Influenza Vaccines Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Swine Influenza Vaccines Manufacturing Cost Structure
Figure 41. Swine Influenza Vaccines Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed